000 | 01947 a2200589 4500 | ||
---|---|---|---|
005 | 20250517151152.0 | ||
264 | 0 | _c20180305 | |
008 | 201803s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.16048 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchrörs, Barbara | |
245 | 0 | 0 |
_aHLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model. _h[electronic resource] |
260 |
_bOncotarget _cApr 2017 |
||
300 |
_a28312-28327 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAntigen Presentation |
650 | 0 | 4 |
_aAntigens, Neoplasm _xgenetics |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aComputational Biology _xmethods |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aEpitope Mapping |
650 | 0 | 4 |
_aEpitopes, T-Lymphocyte _xgenetics |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 | _aGenes, MHC Class I |
650 | 0 | 4 | _aHigh-Throughput Nucleotide Sequencing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aINDEL Mutation |
650 | 0 | 4 |
_aMelanoma _xgenetics |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 |
_aPeptides _xchemistry |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell, alpha-beta _xgenetics |
650 | 0 | 4 |
_aT-Cell Antigen Receptor Specificity _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 | _aTranscriptome |
700 | 1 | _aLübcke, Silke | |
700 | 1 | _aLennerz, Volker | |
700 | 1 | _aFatho, Martina | |
700 | 1 | _aBicker, Anne | |
700 | 1 | _aWölfel, Catherine | |
700 | 1 | _aDerigs, Patrick | |
700 | 1 | _aHankeln, Thomas | |
700 | 1 | _aSchadendorf, Dirk | |
700 | 1 | _aPaschen, Annette | |
700 | 1 | _aWölfel, Thomas | |
773 | 0 |
_tOncotarget _gvol. 8 _gno. 17 _gp. 28312-28327 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.16048 _zAvailable from publisher's website |
999 |
_c27094714 _d27094714 |